Parallax Volatility Advisers’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,576
| Closed | -$552K | – | 1594 |
|
|
2025
Q4 | $552K | Buy |
+1,576
| New | +$533K | ﹤0.01% | 1212 |
|
|
2025
Q1 | – | Sell |
-1
| Closed | -$401 | – | 1723 |
|
|
2024
Q4 | $369 | Sell |
1
-4,283
| -100% | -$1.79M | ﹤0.01% | 1928 |
|
|
2024
Q3 | $2.23M | Buy |
4,284
+579
| +16% | +$309K | ﹤0.01% | 1091 |
|
|
2024
Q2 | $2.01M | Sell |
3,705
-1,197
| -24% | -$633K | ﹤0.01% | 1049 |
|
|
2024
Q1 | $2.54M | Buy |
4,902
+2,258
| +85% | +$1.12M | 0.01% | 952 |
|
|
2023
Q4 | $1.25M | Sell |
2,644
-2,778
| -51% | -$1.28M | ﹤0.01% | 1330 |
|
|
2023
Q3 | $2.36M | Sell |
5,422
-230
| -4% | -$104K | 0.01% | 1034 |
|
|
2023
Q2 | $2.51M | Sell |
5,652
-14,255
| -72% | -$6.58M | 0.01% | 1049 |
|
|
2023
Q1 | $9.15M | Sell |
19,907
-9,583
| -32% | -$4.56M | 0.02% | 619 |
|
|
2022
Q4 | $15.1M | Buy |
29,490
+5,912
| +25% | +$3M | 0.02% | 630 |
|
|
2022
Q3 | $10.7M | Buy |
+23,578
| New | +$11.3M | 0.02% | 746 |
|
|
2022
Q2 | – | Sell |
-419
| Closed | -$207K | – | 2987 |
|
|
2022
Q1 | $206K | Buy |
+419
| New | +$192K | ﹤0.01% | 2173 |
|
|
2021
Q3 | – | Sell |
-49,639
| Closed | -$18.9M | – | 3102 |
|
|
2021
Q2 | $19M | Buy |
49,639
+6,123
| +14% | +$2.34M | 0.02% | 650 |
|
|
2021
Q1 | $15.6M | Sell |
43,516
-25,068
| -37% | -$8.06M | 0.01% | 753 |
|
|
2020
Q4 | $22M | Buy |
68,584
+11,768
| +21% | +$3.61M | 0.02% | 724 |
|
|
2020
Q3 | $15.3M | Buy |
56,816
+16,833
| +42% | +$4.53M | 0.01% | 820 |
|
|
2020
Q2 | $10.5M | Buy |
39,983
+8,402
| +27% | +$2.24M | 0.01% | 763 |
|
|
2020
Q1 | $7.17M | Buy |
31,581
+23,874
| +310% | +$6.51M | 0.01% | 726 |
|
|
2019
Q4 | $2.33M | Sell |
7,707
-1,976
| -20% | -$544K | ﹤0.01% | 1200 |
|
|
2019
Q3 | $2.33M | Sell |
9,683
-14,331
| -60% | -$3.93M | ﹤0.01% | 1081 |
|
|
2019
Q2 | $6.78M | Buy |
24,014
+23,380
| +3,688% | +$6.39M | 0.01% | 630 |
|
|
2019
Q1 | $182K | Sell |
634
-3,845
| -86% | -$1.11M | ﹤0.01% | 1925 |
|
|
2018
Q4 | $1.18M | Buy |
+4,479
| New | +$1.23M | ﹤0.01% | 1254 |
|
|
2018
Q1 | – | Sell |
-6,029
| Closed | -$1.36M | – | 2709 |
|
|
2017
Q4 | $1.36M | Buy |
+6,029
| New | +$1.28M | ﹤0.01% | 1069 |
|
|
2016
Q2 | – | Sell |
-62
| Closed | -$9K | – | 2716 |
|
|
2016
Q1 | $9K | Buy |
+62
| New | +$8.29K | ﹤0.01% | 2342 |
|
|
2015
Q1 | – | Sell |
-3,696
| Closed | -$526K | – | 4606 |
|
|
2014
Q4 | $464K | Sell |
3,696
-13,530
| -79% | -$1.67M | ﹤0.01% | 2110 |
|
|
2014
Q3 | $2.06M | Buy |
17,226
+4,749
| +38% | +$545K | 0.01% | 1100 |
|
|
2014
Q2 | $1.34M | Buy |
12,477
+5,710
| +84% | +$588K | 0.01% | 931 |
|
|
2014
Q1 | $674K | Sell |
6,767
-83,952
| -93% | -$7.59M | ﹤0.01% | 903 |
|
|
2013
Q4 | $8.38M | Buy |
90,719
+56,511
| +165% | +$5.02M | 0.04% | 326 |
|
|
2013
Q3 | $2.86M | Buy |
34,208
+10,215
| +43% | +$875K | 0.02% | 458 |
|
|
2013
Q2 | $1.96M | Buy |
+23,993
| New | +$1.8M | 0.01% | 588 |
|
Other funds holding ELV
Parallax Volatility Advisers's ELV Position: Q1 2026 in Review
Parallax Volatility Advisers sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 1,576 shares — an estimated $552K sold.
Parallax Volatility Advisers first reported a position in ELV in Q2 2013 and held it in 32 quarters. The position peaked at $22M in Q4 2020. 1,469 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Parallax Volatility Advisers reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- Parallax Volatility Advisers sold 1,576 Elevance Health shares in Q1 2026, an estimated $552K.
- Parallax Volatility Advisers first reported a position in Elevance Health in Q2 2013 and held it in 32 quarters.
- Parallax Volatility Advisers's Elevance Health position peaked at $22M in Q4 2020.
- 1,469 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.